search
Back to results

CARINAE for Stress Relief in Perioperative Care (CARINAE)

Primary Purpose

Psychological Stress, Cardiopulmonary Bypass Surgery, Coronary Artery Bypass Surgery

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
SaMD CARINAE
Sponsored by
Adhera Health, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Psychological Stress focused on measuring Pre-operative Stress, mHealth Device, Virtual Reality (VR), Health Recommender System, I-Change Behavioral Change Model, Artificial Intelligence (AI), Software as a Medical Device (SaMD)

Eligibility Criteria

8 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients planned for one of the selected surgery types:
  • Cardiopulmonary bypass (CPB) surgery (Maastricht UMC+)
  • Coronary artery bypass surgery (Maastricht UMC+)
  • Cardiac valve replacement (SAS, Maastricht UMC+)
  • Prostate, kidney, and bladder cancer surgery (INRCA)
  • Hip and knee replacement (HSJD; Parc Tauli)
  • Maxillofacial surgery (HSJD)
  • Orthognathic surgery (HSJD)
  • Scoliosis (HSJD)
  • Signed informed consent (by patient or legal guardian in paediatric cases).
  • Patients ≥ 18 years old, except for paediatric Hospital San Joan de Deu (HSJD) ≥ 8 years old.
  • Patient owns a smartphone with Android version 4.4 or above.
  • Patient (or legal guardian/caregiver in paediatric cases) is able to demonstrate basic digital literacy (e.g. knows how to communicate through instant messaging apps or similar).

Exclusion Criteria:

  • Dementia.
  • Pregnant women.
  • Inability to understand the local language.
  • Allergic to dedicated wearable material (stainless steel and silicone).
  • Currently enrolled in a different clinical trial.

Sites / Locations

  • Istituto di Ricovero e Cura per Anziani
  • Maastricht University Medical Center
  • Hospital Reina Sofía
  • Hospital San Joan de Deu
  • Hospital Parc Taulí

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control Group

SaMD CARINAE

Arm Description

Patients will follow the usual care procedures and after each procedure they answer questionnaires related to pain and stress levels (VAS), Anxiety and depression levels (HADS), health-related quality of life (HRQoL), mental wellbeing (SWEMWBS), self-efficacy (GSE) and Patient Activation status (PAM-13).

Intervention group will be exposed to the use of SaMD CARINAE for 2 months approximately, a patientcentred digital health support program. The intervention trial will include a total of 4 visits: 1. Baseline (2-4 weeks before surgery); 2. Hospital admission (1-3 days before surgery); 3. Hospital discharge (1 week after the surgery approx.); 4. Post-operative day 14 (2 weeks after the surgery approx). After each visit and intervention trial with SaMD CARINAE the experimental group answer the same questionnaires of the control group, above mentioned Participants allocated to the intervention group will also be asked to complete questionnaires about usability, satisfaction and subjective experience.

Outcomes

Primary Outcome Measures

Visual Analog Scale for Stress
Patient and caregiver-reported visual analog scale question to assess subjective stress. Along a 100 mm horizontal line, patient and caregiver indicate their perceived stress intensity. Rating varies from 0 (minimum values) to 100 (maximum value). Ratings of 0 to 4 mm can be considered no stress; 5 to 44 mm, mild stress; 45 to 74 mm, moderate stress; and 75 to 100 mm, severe stress.
Visual Analog Scale for Pain
Patient-reported visual analog scale question to assess subjective pain. Along a 100 mm horizontal line, patient and caregiver indicate their perceived pain intensity. Rating varies from 0 (minimum values) to 100 (maximum value). Ratings of 0 to 4 mm can be considered no pain; 5 to 44 mm, mild pain; 45 to 74 mm, moderate pain; and 75 to 100 mm, severe pain.
Hospital Anxiety and Depression Scale
Patient-reported questionnaire on anxiety and depression levels during the hospital stay. Hospital Anxiety and Depression Scale is a fourteen-item scale with seven items each for anxiety and depression subscales evaluated on a 0-3 Likert Scale. Rating varies from 0 to 21 and a subscale score >8 denotes anxiety or depression.
Health-related Quality of Life - EQ-5D-3L/-Y
Patient-reported questionnaire on quality of life. The questionnaire consists of five items related each to one dimension: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems (1), some problems (2), and extreme problems (3). The maximum score of 1 indicates the best health state, by contrast with the scores of individual questions, where higher scores indicate more severe or frequent problems. In addition, there is a visual analogue scale (VAS) to indicate the general health status with 100 indicating the best health status.
The Positive and Negative Affect Schedule
Patient-reported questionnaire on emotional status. It consists of 20 items that describe n emotions of a positive or negative nature, 10 of them positive and 10 negative. Each item is answered using an Likert-tscale with 5 response options (not at all, very little, somewhat, quite a lot, very much). Scores can range from 10 - 50, with higher scores representing higher levels of positive or negative affect.
The Short Warwick-Edinburgh Mental Well-Being Scale
Patient- and caregiver-reported questionnaire on mental well-being. It consists of 7 items and each item is answered using a 1-5 Likert scale. Scores range from 7 to 35 and higher scores indicate higher positive mental wellbeing.
General Self-Efficacy Scale
Patient- and caregiver-reported questionnaire on self-efficacy perception. It consists of 10 items evaluated on a 1-4 Likert scale. Scores range from 10 to 40 amd higher scores indicate higher self-efficacy.
Patient Activation Measure
Patient-reported questionnaire on the level of activation. It consists of 13 items that have four possible response options ranging from (1) strongly disagree to (4) strongly agree, and an additional "not applicable" option. To calculate the total score, the raw score is divided by the number of items answered (excepting non-applicable items) and multiplied by 13. Then, this score is transformed to a scale with a theoretical range 0-100, based on calibration tables, with higher scores indicating higher patient activation. The raw scores can be converted into four activation levels: 1 (≤47.0) not believing activation important, 2 (47.1-55.1) a lack of knowledge and confidence to take action, 3 (55.2-67.0) beginning to take action and 4 (≥67.1) taking action.

Secondary Outcome Measures

System Usability Scale
Questionnaire on SaMD CARINAE usability by patients, caregivers and healthcare professionals
Usability questionnaire
Ad-hoc questionnaire for patients and healthcare professional on the digital solution usability
Net Promoter Score
Net Promoter Score (NPS) is a questionnaire that measures patient and healthcare professionals experience and provides the core measurement for customer experience management programs.
Reliability
Ad-Hoc questionnaire for the healthcare professional on the digital solution

Full Information

First Posted
November 29, 2021
Last Updated
July 29, 2022
Sponsor
Adhera Health, Inc.
Collaborators
Maastricht University Medical Center, Hospital Sant Joan de Deu, Parc Taulí Hospital Universitari, Hospital Universitario Reina Sofia de Cordoba, Istituto Nazionale di Ricovero e Cura per Anziani
search

1. Study Identification

Unique Protocol Identification Number
NCT05184725
Brief Title
CARINAE for Stress Relief in Perioperative Care
Acronym
CARINAE
Official Title
CARINAE: A Digital Health Intervention for Stress Relief in Perioperative Care: Clinical Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
January 10, 2022 (Actual)
Primary Completion Date
April 30, 2022 (Actual)
Study Completion Date
May 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Adhera Health, Inc.
Collaborators
Maastricht University Medical Center, Hospital Sant Joan de Deu, Parc Taulí Hospital Universitari, Hospital Universitario Reina Sofia de Cordoba, Istituto Nazionale di Ricovero e Cura per Anziani

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Preventing pre-surgical stress can help patients achieve positive outcomes on health and well-being. However, very few patients receive adequate stress relief support prior to a surgical procedure. Provision of education and information about the surgery can be a crucial component of the preoperative experience and is inversely related to levels of preoperative anxiety. However, resource constraints make face-to-face education sessions untenable, given cost considerations and time investment by trained health personnel. Interventions based on mobile health (mHealth) technologies, geared towards increasing familiarity with surgical procedures and hospital environments have been shown to help patients feel informed about possible benefits and risks of available treatment options. mHealth apps and Virtual Reality (VR) can offer patients experience in the perioperative environment that can be helpful in empowering patients and enhancing a more positive experience, while reducing stress. However, available applications focus only on providing informative content, neglecting the importance of patient empowerment with a more robust educational curriculum. According to this, the Software as a Medical Device (SaMD) CARINAE, aims to support patients and caregivers during the whole perioperative process. SaMD CARINAE consists of an mHealth mobile application for patients and caregivers, a Virtual Reality headset for patients, and a web application for healthcare professionals.
Detailed Description
Patients will be randomly assigned to intervention group or the control group. Intervention group will be exposed to the use of SaMD CARINAE for 2 months approximately. The intervention trial will include a total of 4 visits: 1. Recruitment; 2. Hospital admission; 3. Hospital discharge; 4. Post-operative follow-up in 14 days. SaMD CARINAE delivers the following interventions to the patients: Personalised patient-centred health education program to improve patient's condition and recovery self-management skills. Artificial Intelligence-based behaviour change program to promote healthier lifestyle habits. Personalised mental well-being coaching program to improve patient's ability to cope with emotional disturbances such as stress and anxiety. A collaborative digital support platform to enable information exchange between patients, caregivers, and healthcare professionals. The program is delivered to patients and caregivers as a SaMD mHealth application (smartphone app) and an immersive environment with a VR device. Healthcare professionals will be able to access the collaborative digital support platform through a web application. Finally, the control group will not be exposed to SaMD CARINAE solution, following the traditional routine visits, and after each traditional visit patients will answer to questionnaires specified in the secondary outcome measures section.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychological Stress, Cardiopulmonary Bypass Surgery, Coronary Artery Bypass Surgery, Cardiac Valve Replacement, Hip Replacement, Orthognathic Surgery, Scoliosis, Knee Replacement, Prostate Cancer, Kidney Cancer, Bladder Cancer
Keywords
Pre-operative Stress, mHealth Device, Virtual Reality (VR), Health Recommender System, I-Change Behavioral Change Model, Artificial Intelligence (AI), Software as a Medical Device (SaMD)

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The SaMD CARINAE embeds the I-Change Model, which claims that behavioral changes depend on the inner motivation to perform a specific behavior and the self-perception of personal abilities, or self-efficacy perception, to carry out the behavioral change.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Patients will follow the usual care procedures and after each procedure they answer questionnaires related to pain and stress levels (VAS), Anxiety and depression levels (HADS), health-related quality of life (HRQoL), mental wellbeing (SWEMWBS), self-efficacy (GSE) and Patient Activation status (PAM-13).
Arm Title
SaMD CARINAE
Arm Type
Experimental
Arm Description
Intervention group will be exposed to the use of SaMD CARINAE for 2 months approximately, a patientcentred digital health support program. The intervention trial will include a total of 4 visits: 1. Baseline (2-4 weeks before surgery); 2. Hospital admission (1-3 days before surgery); 3. Hospital discharge (1 week after the surgery approx.); 4. Post-operative day 14 (2 weeks after the surgery approx). After each visit and intervention trial with SaMD CARINAE the experimental group answer the same questionnaires of the control group, above mentioned Participants allocated to the intervention group will also be asked to complete questionnaires about usability, satisfaction and subjective experience.
Intervention Type
Device
Intervention Name(s)
SaMD CARINAE
Intervention Description
SaMD CARINAE delivers the following digital therapeutic intervention to the patients: 1) Personalised patient-centred health education program to improve patient's disease and recovery self-management skills. 2) AI-based behaviour change program to promote healthier lifestyle habits. 3) Personalised mental well-being coaching program to improve patient's ability to cope with emotional disturbances such as stress and anxiety. 4) A collaborative digital support platform to enable information exchange between patients, caregivers, and healthcare professionals.
Primary Outcome Measure Information:
Title
Visual Analog Scale for Stress
Description
Patient and caregiver-reported visual analog scale question to assess subjective stress. Along a 100 mm horizontal line, patient and caregiver indicate their perceived stress intensity. Rating varies from 0 (minimum values) to 100 (maximum value). Ratings of 0 to 4 mm can be considered no stress; 5 to 44 mm, mild stress; 45 to 74 mm, moderate stress; and 75 to 100 mm, severe stress.
Time Frame
2 months: from baseline to 14 days after the surgery
Title
Visual Analog Scale for Pain
Description
Patient-reported visual analog scale question to assess subjective pain. Along a 100 mm horizontal line, patient and caregiver indicate their perceived pain intensity. Rating varies from 0 (minimum values) to 100 (maximum value). Ratings of 0 to 4 mm can be considered no pain; 5 to 44 mm, mild pain; 45 to 74 mm, moderate pain; and 75 to 100 mm, severe pain.
Time Frame
2 months: from baseline to 14 days after the surgery
Title
Hospital Anxiety and Depression Scale
Description
Patient-reported questionnaire on anxiety and depression levels during the hospital stay. Hospital Anxiety and Depression Scale is a fourteen-item scale with seven items each for anxiety and depression subscales evaluated on a 0-3 Likert Scale. Rating varies from 0 to 21 and a subscale score >8 denotes anxiety or depression.
Time Frame
45 days: From hospital admission to 14 days after the surgery
Title
Health-related Quality of Life - EQ-5D-3L/-Y
Description
Patient-reported questionnaire on quality of life. The questionnaire consists of five items related each to one dimension: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems (1), some problems (2), and extreme problems (3). The maximum score of 1 indicates the best health state, by contrast with the scores of individual questions, where higher scores indicate more severe or frequent problems. In addition, there is a visual analogue scale (VAS) to indicate the general health status with 100 indicating the best health status.
Time Frame
45 days: From hospital admission to 14 days after the surgery
Title
The Positive and Negative Affect Schedule
Description
Patient-reported questionnaire on emotional status. It consists of 20 items that describe n emotions of a positive or negative nature, 10 of them positive and 10 negative. Each item is answered using an Likert-tscale with 5 response options (not at all, very little, somewhat, quite a lot, very much). Scores can range from 10 - 50, with higher scores representing higher levels of positive or negative affect.
Time Frame
45 days: From hospital admission to 14 days after the surgery
Title
The Short Warwick-Edinburgh Mental Well-Being Scale
Description
Patient- and caregiver-reported questionnaire on mental well-being. It consists of 7 items and each item is answered using a 1-5 Likert scale. Scores range from 7 to 35 and higher scores indicate higher positive mental wellbeing.
Time Frame
2 months: from baseline to 14 days after the surgery
Title
General Self-Efficacy Scale
Description
Patient- and caregiver-reported questionnaire on self-efficacy perception. It consists of 10 items evaluated on a 1-4 Likert scale. Scores range from 10 to 40 amd higher scores indicate higher self-efficacy.
Time Frame
2 months: from baseline to 14 days after the surgery
Title
Patient Activation Measure
Description
Patient-reported questionnaire on the level of activation. It consists of 13 items that have four possible response options ranging from (1) strongly disagree to (4) strongly agree, and an additional "not applicable" option. To calculate the total score, the raw score is divided by the number of items answered (excepting non-applicable items) and multiplied by 13. Then, this score is transformed to a scale with a theoretical range 0-100, based on calibration tables, with higher scores indicating higher patient activation. The raw scores can be converted into four activation levels: 1 (≤47.0) not believing activation important, 2 (47.1-55.1) a lack of knowledge and confidence to take action, 3 (55.2-67.0) beginning to take action and 4 (≥67.1) taking action.
Time Frame
45 days: From baseline to hospital discharge
Secondary Outcome Measure Information:
Title
System Usability Scale
Description
Questionnaire on SaMD CARINAE usability by patients, caregivers and healthcare professionals
Time Frame
30 days: from hospital admission to 14 days after surgery
Title
Usability questionnaire
Description
Ad-hoc questionnaire for patients and healthcare professional on the digital solution usability
Time Frame
30 days: from hospital admission to 14 days after surgery
Title
Net Promoter Score
Description
Net Promoter Score (NPS) is a questionnaire that measures patient and healthcare professionals experience and provides the core measurement for customer experience management programs.
Time Frame
30 days: from hospital admission to 14 days after surgery
Title
Reliability
Description
Ad-Hoc questionnaire for the healthcare professional on the digital solution
Time Frame
Day 60

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients planned for one of the selected surgery types: Cardiopulmonary bypass (CPB) surgery (Maastricht UMC+) Coronary artery bypass surgery (Maastricht UMC+) Cardiac valve replacement (SAS, Maastricht UMC+) Prostate, kidney, and bladder cancer surgery (INRCA) Hip and knee replacement (HSJD; Parc Tauli) Maxillofacial surgery (HSJD) Orthognathic surgery (HSJD) Scoliosis (HSJD) Signed informed consent (by patient or legal guardian in paediatric cases). Patients ≥ 18 years old, except for paediatric Hospital San Joan de Deu (HSJD) ≥ 8 years old. Patient owns a smartphone with Android version 4.4 or above. Patient (or legal guardian/caregiver in paediatric cases) is able to demonstrate basic digital literacy (e.g. knows how to communicate through instant messaging apps or similar). Exclusion Criteria: Dementia. Pregnant women. Inability to understand the local language. Allergic to dedicated wearable material (stainless steel and silicone). Currently enrolled in a different clinical trial.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Clara Hernández Cera
Organizational Affiliation
Hospital San Joan de Deu
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ignacio Muñoz Carvajal
Organizational Affiliation
Hospital Universitario Reina Sofía
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Juan José Lázaro Alcay
Organizational Affiliation
Hospital San Joan de Deu
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Andrea Vallejo Tarrat
Organizational Affiliation
Parc Taulí Hospital Universitari
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
JG Maessen, Prof. dr.
Organizational Affiliation
Maastricht University Medical Center
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Marco Dellabella
Organizational Affiliation
Istituto di Ricovero e Cura per Anziani
Official's Role
Study Chair
Facility Information:
Facility Name
Istituto di Ricovero e Cura per Anziani
City
Ancona
Country
Italy
Facility Name
Maastricht University Medical Center
City
Maastricht
Country
Netherlands
Facility Name
Hospital Reina Sofía
City
Córdoba
State/Province
Andalucía
ZIP/Postal Code
14004
Country
Spain
Facility Name
Hospital San Joan de Deu
City
Esplugues De Llobregat
State/Province
Catalunya
ZIP/Postal Code
08950
Country
Spain
Facility Name
Hospital Parc Taulí
City
Sabadell
State/Province
Catalunya
ZIP/Postal Code
08208
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
Citation
Crichton, N. Visual analogue scale (VAS). J Clin Nurs. 2001; 10(5): 706-6.
Results Reference
background
PubMed Identifier
6880820
Citation
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
Results Reference
background
PubMed Identifier
3397865
Citation
Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.
Results Reference
background
PubMed Identifier
19228398
Citation
Stewart-Brown S, Tennant A, Tennant R, Platt S, Parkinson J, Weich S. Internal construct validity of the Warwick-Edinburgh Mental Well-being Scale (WEMWBS): a Rasch analysis using data from the Scottish Health Education Population Survey. Health Qual Life Outcomes. 2009 Feb 19;7:15. doi: 10.1186/1477-7525-7-15.
Results Reference
background
Citation
Schwarzer, R., & Jerusalem, M. Generalized Self-Efficacy scale. In J. Weinman, S. Wright, & M. Johnston, Measures in health psychology: A user's portfolio. Causal and control beliefs. Windsor, UK: NFER-NELSON. 1995; 35-37.
Results Reference
background
PubMed Identifier
15230939
Citation
Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26. doi: 10.1111/j.1475-6773.2004.00269.x.
Results Reference
background
Citation
Brooke, J. SUS-A quick and dirty usability scale. Usability evaluation in industry. 1996; 189(194): 4-7.
Results Reference
background
PubMed Identifier
14712543
Citation
Reichheld FF. The one number you need to grow. Harv Bus Rev. 2003 Dec;81(12):46-54, 124.
Results Reference
background

Learn more about this trial

CARINAE for Stress Relief in Perioperative Care

We'll reach out to this number within 24 hrs